Bolton Medical has completed patient enrolment in a Phase I trial designed to evaluate the safety and efficacy of the Treovance abdominal stent-graft with the Navitel delivery system in the endovascular aortic repair of abdominal aortic aneurysms.
The Trevoance abdominal stent-graft offers advantages through its size-range and multiple fixation points, while the Navitel delivery system is equipped with a detachable sheath that allows for controlled or rapid deployment.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Phase I trial includes 30 patients at six centres across the US.
The company plans to conduct a pivotal Phase II trial in 2012.
